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Abstract 
Background: cis, cis-Muconic acid is an important chemical that can be biosynthesized from simple substrates in 
engineered microorganisms. Recently, it has been shown that engineering microbial cocultures is an emerging and 
promising approach for biochemical production. In this study, we aim to explore the potential of the E. coli–E. coli 
coculture system to use a single renewable carbon source, glycerol, for the production of value-added product cis, 
cis-muconic acid.
Results: Two coculture engineering strategies were investigated. In the first strategy, an E. coli strain containing 
the complete biosynthesis pathway was co-cultivated with another E. coli strain containing only a heterologous 
intermediate-to-product biosynthetic pathway. In the second strategy, the upstream and downstream pathways 
were accommodated in two separate E. coli strains, each of which was dedicated to one portion of the biosynthesis 
process. Compared with the monoculture approach, both coculture engineering strategies improved the production 
significantly. Using a batch bioreactor, the engineered coculture achieved a 2 g/L muconic acid production with a 
yield of 0.1 g/g.
Conclusions: Our results demonstrate that coculture engineering is a viable option for producing muconic acid from 
glycerol. Moreover, microbial coculture systems are shown to have the potential for converting single carbon source 
to value-added products.
Keywords: Metabolic engineering, E. coli, Coculture, Muconic acid, Glycerol
© 2015 Zhang et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
cis, cis-muconic acid (MA) is a diunsaturated linear 
dicarboxylic acid with recognized industrial applications. 
One of the primary uses of MA is to make adipic acid 
through hydrogenation [1–4]. As a precursor for the syn-
thesis of several commodity chemicals, such as nylon and 
polyurethane, adipic acid has a long history of commer-
cial applications in the plastics industry. In addition, MA 
can be utilized as the starting material for making tere-
phthalic acid, which is one of the two constituent mono-
mers of the high-demand plastic polymer polyethylene 
terephthalate (PET) [5]. Adipic acid and terephthalic acid 
also have wide applications in the cosmetic, pharmaceu-
tical and food industries [1]. However, current industrial 
production of adipic acid and terephthalic acid relies 
exclusively on utilization of petroleum and coal feed-
stocks through chemical conversion processes, which has 
encountered major challenges due to the increasing sus-
tainability, environmental and economic concerns.
Development of new production methods utilizing 
renewable resources, such as biomass feedstocks, offers 
more sustainable ways for producing valuable bulk com-
pounds [6]. This has fueled extensive research interest 
in the engineering of microbes to achieve MA biosyn-
thesis from simple renewable carbon substrates [1]. The 
use of microorganisms to convert aromatics to MA has 
been demonstrated before; however, the starting mate-
rials used in these reports, such as toluene and benzoic 
acid, are derived from petroleum or coal raw materials 
[7–13]. The first complete MA biosynthesis from glu-
cose, a renewable sugar, was established in engineered 
E. coli by the Frost group, which utilized the metabolite 
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3-dehydroshikimic acid as key biosynthesis precursor [3, 
14]. Further optimization of this biosynthetic pathway 
resulted in 18  g/L MA production from glucose using 
a fed-batch bioreactor [4]. The same pathway was also 
employed to biosynthesize MA in the yeast S. cerevisiae, 
although the reported titers and yields of these studies 
were significantly lower due to the challenge of achiev-
ing sufficient functional expression of the heterologous 
pathway enzymes [15, 16]. In addition, Lin et  al. [17] 
established a new MA biosynthetic route via salicyclic 
acid and achieved a MA production of 1.5 g/L. The same 
group also demonstrated a biosynthetic pathway in E. coli 
leading from simple carbon sources to MA via anthra-
nilate [18].
Recently, our group developed a novel metabolic engi-
neering approach based on a coculture concept [19] 
and successfully utilized it for achieving high-yield MA 
biosynthesis from sugar mixtures that can be derived 
from lignocellulose [20]. In the present study, we further 
explore the potential of the microbial coculture approach 
by using a single carbon source, glycerol, to biosynthe-
size MA. Although E. coli–E. coli cocultures have been 
utilized to produce small molecules, such as lactic acid, 
previous studies focused on utilizing different carbon 
sources [21, 22]. Other studies engineered E. coli cocul-
tures for the production of more complex molecules. 
For example, Saini et al. [23] employed an E. coli–E. coli 
coculture for biosynthesis of n-butanol from sole carbon 
source glucose. The novelty of the present study is the use 
of cocultures to balance metabolic pathways harboring a 
very slow step that leads to secretion of pathway inter-
mediates and, as a result, low product yields. By using 
the coculture consisting of two different strains, the low 
activity of an enzyme can be overcome by increasing the 
relative amount of the strain harboring the slow step.
On the other hand, we aimed to produce value-added 
MA from the renewable and inexpensive glycerol sub-
strate. As a major byproduct of the biodiesel industry 
(roughly 10  % w/w), crude glycerol is produced in sur-
plus amounts relatively to the global market demand. 
Moreover, disposal of glycerol can cause environmental 
issues and thus needs to meet regulatory requirements 
that increase the operational cost of biodiesel produc-
tion. Nevertheless, glycerol can be efficiently utilized by 
a variety of microbes for growth, and the related biodeg-
radation pathways have been well studied. It is therefore 
of great research and industrial significance to develop 
new bioprocesses that convert glycerol to valuable com-
pounds [24–26]. This study reports the conversion of 
the substrate glycerol to cis, cis-muconic acid using engi-
neered E. coli–E. coli cocultures.
Results and discussion
MA synthesis from glycerol using an E. coli monoculture
Several MA biosynthetic pathways have been assembled 
in heterologous microorganisms for de novo MA syn-
thesis from simple carbon substrates [4, 17, 18]. In this 
study, we chose to use the biosynthetic route that makes 
MA through three enzymatic reactions via intermedi-
ates 3-dehydroshikimic acid (DHS), protocatechuic acid 
(PCA) and catechol (CA) (Fig. 1). Heterologous enzymes 
DHS dehydratase (AroZ) and PCA decarboxylase (AroY) 
from Klebsiella pneumonia and CA 1,2-dioxygenase 
(CatA) from Acinetobacter calcoaceticus were used to 
establish this pathway [4, 20]. An E. coli tyrosine over-
producer was selected to accommodate the MA biosyn-
thetic pathway, as this strain has an engineered shikimate 
pathway to efficiently produce the required DHS inter-
mediate. Two competing genes, including ydiB and aroE, 
were deleted from the E. coli chromosome to yield strain 
P5 that eliminated the undesired conversion of DHS to 
the shikimate pathway downstream products. The intro-
duction of the MA biosynthetic pathway in E. coli P5 
yielded strain P5g. When MA biosynthesis was induced 
at the beginning of cultivation, it was observed that P5g 
grew poorly on glycerol, indicating that overexpression 
of the pathway enzymes imposed significant metabolic 
stress on E. coli and thus impaired its growth. This issue 
was addressed by the delayed addition of the inducer 
IPTG 24  h after inoculation. Under this condition, P5g 
grew better and was able to make 316  mg/L MA from 
10  g/L glycerol. Consistent with our previous finding 
[20], a high titer of the intermediate DHS accumulated in 
the medium, suggesting that availability of intracellular 
DHS could be limiting MA production.
It has been reported that an endogenous E. coli mem-
brane-bound transporter, ShiA permease, can mediate 
DHS trans-membrane transport and, as such, can be 
utilized for DHS assimilation [20]. Hence, the shiA gene 
was over-expressed in E. coli to improve DHS importa-
tion and increase the intracellular DHS-to-MA conver-
sion. As shown in Fig.  2, this strategy indeed increased 
MA production to 473  mg/L in the resulting strain E. 
coli P5s, accompanied by a slight decrease in total DHS 
accumulation.
In an effort to further improve DHS conversion, the 
downstream pathway enzyme AroZ, responsible for the 
DHS-to-PCA conversion, was fused to the ShiA per-
mease so that imported DHS could be immediately pro-
cessed by AroZ to produce the intermediate PCA before 
leaking out of the cell again. However, E. coli P5fs con-
structed using this design did not show any significant 
improvement of MA production (Fig.  2). In another 
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construct, the AroZ enzyme was engineered to be local-
ized in the periplasmic space between the E. coli inner 
and outer membranes through the use of a phage gIII 
capsid protein signal sequence [27, 28]. In this construct, 
imported DHS would not need to travel across both cell 
membranes to gain access to the cytosolic AroZ enzyme 
for downstream conversion, which could potentially alle-
viate any DHS cross-membrane transportation issues and 
improve downstream conversion efficiency. However, 
this strategy turned out to be unsuccessful and actually 
resulted in decreased MA production (Fig. 2). The reason 
could be that the periplasmic expression of AroZ gener-
ated a physiological impact on cell’s fitness and decreased 
the cell’s production performance.
MA production by a coculture of E. coli P5.2 and BLS
The lack of MA production improvement by the above 
metabolic engineering efforts suggested that alternative 
methods should be deployed in order to reduce DHS 
accumulation. To this end, we employed an E. coli–E. coli 
coculture engineering approach to improve MA biosyn-
thesis from glycerol. In fact, a previous report demon-
strated a coculture system for converting sugar mixtures 
to the MA product [20]. Here, we further explored the 
potential of coculture engineering to utilize a single car-
bon source, glycerol.
Considering that there was still a high level of DHS 
intermediate accumulation in the E. coli P5s mono-
culture, we next supplemented a second E. coli strain 
overexpressing the heterologous enzymes AroZ, AroY 
and CatA and the ShiA permease to better utilize the 
secreted DHS (Fig.  3a). This strain, named BLS, was in 
fact derived from E. coli BL21(DE3) that had been found 
to better support heterologous enzyme activity for the 
MA biosynthetic pathway [20]. It should be noted that E. 
coli BLS did not have an engineered shikimate pathway 
and thus could only utilize DHS secreted from P5s for 
MA biosynthesis. When P5s and BLS were co-cultivated, 
the MA production showed varied profiles depending on 
the inoculation ratio (Table 1). When the P5s:BLS inocu-
lation ratio was decreased by the addition of more BLS 
in the coculture system, the DHS conversion capacity 
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Fig. 2 MA production by monoculture engineering strategies. P5g, 
E. coli with the engineered shikimate pathway and reconstituted MA 
biosynthetic pathway. P5s, P5g overexpressing the ShiA permease. 
P5fs, P5g with fusion expression of AroZ and ShiA. P5pZ, P5g with 
AroZ localized in the periplasmic space. Dark column MA, dark grey 
CA, grey PCA, white DHS. Error bars are SEM obtained from at least 
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was improved. Accordingly, DHS decreased while MA 
concentration increased. However, there is a maximum 
in the amount of the BLS strain in the inoculum beyond 
which DHS conversion to MA was not improved, as 
the relative population size of P5s in the coculture was 
repressed for providing the DHS intermediate for MA 
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Fig. 3 MA production by utilization of E. coli–E. coli cocultures. a Schematic of the coculture design to use a second cell BLS or BLH to work with P5s 
for MA production. b Schematic of the coculture design to split the complete biosynthetic pathway between upstream P5.2 and downstream BS 
or BC cells. b Production optimization by varying the inoculation ratio of P5.2 and BS. c Production optimization by varying the inoculation ratio of 
P5.2 and BC. Error bars are SEM obtained from at least three biological replicates
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formation. These constructs yielded a highest MA pro-
duction of 639 mg/L and yield of 0.064 g/g at an inocula-
tion ratio of 1:1. However, despite improvement of MA 
production, DHS was still not completely converted in 
the P5s:BLS coculture system.
Utilization of E. coli chaperones in the P5s:BLH coculture 
system
Next, we attempted to enhance the DHS-to-MA conver-
sion by improving the heterologous enzymes’ activity 
with the help of E. coli chaperones. Specifically, a new 
E. coli strain BLH was constructed to over-express the 
E. coli GroEL/GroES chaperones as well as the enzymes 
AroZ, AroY, CatA and ShiA. When BLH was co-culti-
vated with P5s, DHS accumulation was also reduced, 
similar to what was observed for the P5s:BLS coculture, 
as shown in Table  2. Optimization of the inoculation 
ratio of P5s:BLH resulted in a production of 691  mg/L 
MA and 255 mg/L DHS. Under the optimal inoculation 
ratio, the MA product concentration and yield were both 
comparable to what was achieved by the P5s:BLS cocul-
ture, indicating that addition of E. coli chaperone systems 
did not make a significant impact on the MA biosynthe-
sis. Notably, the optimal inoculation ratios of P5s:BLS 
and P5s:BLH are different, which could be due to the 
varied growth rate and DHS-to-MA conversion capacity 
between BLS and BLH.
Despite different engineering strategies to improve 
DHS conversion in the monoculture strategy, such as uti-
lization of the ShiA transporter, fusion expression of ShiA 
and AroZ, and periplasmic expression of AroZ, DHS 
accumulation was not completely eliminated in engi-
neered E. coli. In contrast, when a second E. coli strain 
containing the DHS-to-MA pathway was introduced into 
the production process, more DHS conversion capac-
ity was provided and DHS was better converted to the 
final MA product. In both cases of P5s:BLS and P5s:BLH 
cocultures, the benefit of increasing DHS-to-MA conver-
sion outweighed the disadvantage of introduced growth 
competition between the two constituent strains. As 
a result, significant MA production improvement was 
observed.
Splitting the MA biosynthesis pathway between two 
strains cultivated in coculture
We next split the entire MA biosynthetic pathway into 
two modules, each of which was accommodated in a 
separate E. coli strain. The upstream strain E. coli P5.2 
contained only the shikimate pathway ending with the 
synthesis of DHS, whereas the downstream strain E. coli 
BS was equipped with enzymes AroZ, AroY, CatA and 
ShiA under the control of the inducible T7 promoter to 
assimilate and convert DHS to MA. The overall design of 
this new coculture strategy is shown in Fig. 3b.
Table 1 Production of MA using P5s:BLS coculture
Product and intermediate concentrations (mg/L) Yield (g/g)
MA CA PCA DHS
P5s 473 ± 31 114 ± 20 130 ± 26 562 ± 33 0.047
P5s:BLS inoculation ratio 1:0.25 416 ± 33 160 ± 48 92 ± 17 223 ± 33 0.042
1:0.5 562 ± 52 114 ± 22 95 ± 18 194 ± 15 0.056
1:1 639 ± 83 230 ± 38 69 ± 12 198 ± 14 0.064
1:1.5 418 ± 80 152 ± 39 78 ± 30 164 ± 31 0.042
BLS 26 ± 2 8 ± 5 0.2 ± 0.2 1.1 ± 0.7 0.003
Table 2 Production of MA using P5s:BLH coculture
Product and intermediate concentrations (mg/L) Yield (g/g)
MA CA PCA DHS
P5s 473 ± 31 114 ± 20 130 ± 26 562 ± 33 0.047
P5s:BLH inoculation ratio 1:0.25 591 ± 57 182 ± 50 143 ± 3 238 ± 32 0.059
1:0.5 691 ± 112 189 ± 76 114 ± 25 255 ± 42 0.069
1:1 488 ± 55 77 ± 26 47 ± 3 144 ± 24 0.049
1:1.5 480 ± 3 79 ± 10 109 ± 26 123 ± 15 0.048
BLH 128 ± 21 190 ± 56 33 ± 6.0 3.2 ± 2.5 0.013
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Consistent with previous observations, MA produc-
tion depended on the inoculation ratio of P5.2 and BS 
(Fig.  3c). The highest MA production of 758  mg/L was 
achieved at the inoculation ratio of 1:1, indicating that 
the upstream and downstream pathways were best bal-
anced for the complete glycerol-to-MA biosynthesis 
process under this condition. Although the DHS con-
centration gradually decreased as more BS cells were 
supplemented in the cocultures, DHS accumulation 
was still observed even at the highest inoculation ratio. 
This finding suggested that inducible expression of the 
enzymes responsible for DHS to MA conversion was not 
the best strategy for eliminating DHS accumulation. In 
fact, it was observed before that use of a milder constitu-
tive expression strategy helped improve MA biosynthe-
sis [20]. Therefore, we constructed a new downstream 
strain E. coli BC that over-expressed the downstream 
pathway enzymes and the ShiA permease under the 
control of a constitutive pyruvate decarboxylase pro-
moter isolated from Zymomonas mobilis. It should be 
noted that the upstream strain P5.2 also used constitu-
tive promoters for DHS biosynthesis and thus the new 
P5.2:BC coculture system did not need any inducer for 
MA biosynthesis.
As shown in Fig.  3d, MA production with the new 
coculture system of P5.2:BC was improved at all inoc-
ulation ratios. At the optimal inoculation ratio of 1:1, 
MA concentrations reached 1016  mg/L. Moreover, 
DHS accumulation was also further reduced in this new 
coculture system. Notably, constitutive expression of 
the entire biosynthetic pathway in a single strain sys-
tem, E. coli P5cS, resulted in poor growth and reduced 
MA production (56 mg/L), due to overwhelming meta-
bolic burden imposed by consolidated over-expression 
of all pathway enzymes. These findings together suggest 
that lessening the metabolic stress on the microbial host 
improved its fitness for functional expression of the het-
erologous downstream enzymes; and the production 
improvement shown here highlights the importance 
and usefulness of the coculture strategy to address this 
issue.
We further analyzed the dynamic production profile 
during the P5.2:BC coculture cultivation process. As 
shown in Fig. 4, the DHS concentration peaked at 48 h, 
followed by a significant decrease in the next 48 h, indi-
cating that the downstream DHS conversion capacity 
provided by BC exceeded the upstream DHS formation 
capacity after 48 h. In comparison, accumulation of PCA 
and CA intermediates was maintained at relatively low 
levels, although their concentration started to increase 
toward the end of the production process. The MA final 
product concentration stably increased with time over 
the whole co-culturing process.
Bioreactor production
We next attempted to further increase MA biosynthesis 
by scaling up the coculture production process in a batch 
bioreactor. Specifically, E. coli P5.2 and BC were co-culti-
vated on 20 g/L glycerol at the inoculation ratio of 1:1. As 
shown in Fig.  5a, the overall cell density of the P5.2:BC 
coculture reached ca. OD600 =  10 after 24 h, and stabi-
lized at this level until the end of cultivation. The glycerol 
substrate was rapidly consumed at the early stage of the 
bioreactor production, and depleted at 36 h. As the two 
constituent strains in the coculture competed for glyc-
erol as carbon source, the growth interaction between 
them was highly dynamic. In fact, BC percentage in the 
coculture population fluctuated around 50 % in the first 
36  h. A significant decline of BC percentage was then 
observed after 36 h, which should be due to the relative 
poor growth of BC expressing the heterologous enzymes 
upon the depletion of the glycerol carbon source.
The MA and intermediate production profiles are 
shown in Fig.  5b. The concentrations of intermediates 
CA, PCA and DHS were repressed throughout the cul-
tivation process, indicating that these intermediates were 
well converted to downstream products in the down-
stream strain BC. The MA concentration increased rap-
idly within the first 36 h, and then plateaued at 2 g/L due 
to depletion of the glycerol substrate. The highest pro-
duction yield of 0.1 g/g is similar to the results achieved 
in the previous section. The development of the produc-
tion curves in Fig.  5b demonstrates that the intermedi-
ate-to-MA conversion capacity was reduced after 36  h, 
which is consistent with the decline of BC sub-popula-
tion caused by the glycerol depletion.
The theoretical maximum yield for the pathway leading 
from glycerol to MA is calculated as 0.66 g/g, using the 
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equation for pathway balance 7 Glycerol + 4 ATP + 10 
NAD = 3 MA + 3 CO2 + 4 ADP + 10 NADH. Although 
carbon loss for biomass formation and respiration is not 
considered, the achieved yield is significantly lower than 
the theoretical maximum, indicating that there is room 
for further engineering efforts to improve MA produc-
tion yield.
Conclusions
We report a coculture engineering approach to convert 
renewable glycerol substrate to an important value-
added product. Through step-wise engineering and 
optimization efforts, we significantly improved the prod-
uct concentration and yield. We also demonstrate that, 
despite growth competition between the two strains, 
the E. coli–E. coli coculture can be used in the context 
of sole carbon source for complex biosynthesis pathway 
engineering. The results of this study indicate that the 
combination of pathway modularization and microbial 
co-cultivation has strong potential for future metabolic 
engineering studies.
Methods
Plasmid and strain construction
Gene cloning and bacterial transformations were carried 
out according to the standard protocols [29]. PCR prim-
ers were purchased from Lifetechnologies (Grand Island, 
NY, USA). Phusion DNA Polymerase for PCR amplifica-
tion endonucleases, and the Gibson assembly kit used 
in this study were purchased from New England Biolabs 
(Ipswich, MA, USA). Chaperone expression plasmid pG-
KJE was purchased from Clontech Laboratories (Moun-
tain View, CA, USA).
Some of the plasmids and strains used in this study 
were constructed in our previous research [20]. Addi-
tionally, we constructed several plasmids and E. coli 
strains for MA production from glycerol. To con-
struct plasmid pYfsZ, the shiA gene was PCR amplified 
using primers GAGAAAAACCAAGGCAGTGCCAA 
GTGAAGCTTTCAAGGAGGAACAGACATGG and 
CGCTGCCGCTACCAG CGCGTTGACTGTCTTTC; 
the aroZ gene was PCR amplified using primers CAGTCAA 
CGCGCTGGTAGCGGCAGCGGTAGCGGTAGC 
GGCAGCCTGCGTA GCATTGCCAC and ATCTC 
AGTGGTGGTGGTGGTGGTGCTTAACAGTACTG C 
ATTGCTGCTAAACG. Plasmid pY constructed previ-
ously [20] was then linearized with SpeI and XhoI restric-
tion enzymes and assembled with the shiA and aroZ genes 
using the Gibson assembly kit. The resulting plasmid 
pYfsZ expressed the aroZ and shiA enzyme in the form 
of a fusion protein through a flexible glycine-serine con-
necting linker. To construct plasmid pYpZ, the aroZ gene 
was PCR amplified from plasmid pZ [20] using prim-
ers CGTCTAGAAAGGAGGAACAGACATGAAAA 
AACTGCTGTTCGCGATTCCGCTGGTGGTGC-
CGTTCTATAGCCATAGCATGCTGCGTAGCATTGC 
(containing a phage gIII capsid protein signal sequence) 
and CTCGAGGCACTAGTTTAACA. The PCR product 
was XbaI and XhoI digested and ligated with plasmid pY 
digested with the same restriction enzymes. The plas-
mids were transformed into the desired E. coli strains by 
electroporation. A complete list of the plasmids and E. 
coli strains used in this study is presented in the Table 3.
Cultivation conditions
The MA biosynthesis was conducted using a glycerol 
medium. 1  L glycerol medium contained 10  g glyc-
erol, 2.0 g NH4Cl, 5.0 g (NH4)2SO4, 3.0 g KH2PO4, 7.3 g 
K2HPO4, 8.4  g MOPS, 0.5  g NaCl, 0.24  g MgSO4, 0.5  g 
yeast extract, 40 mg tyrosine, 40 mg phenylalanine, 40 mg 
tryptophan, 10  mg 4-hydroxybenzoic acid, 0.4  mg/L 
Na2EDTA, 0.03  mg H3BO3, 1  mg thiamine, 0.94  mg 
ZnCl2, 0.5  mg CoCl2, 0.38  mg CuCl2, 1.6  mg MnCl2, 
3.77 mg CaCl2, and 3.6 mg FeCl2. The initial medium pH 
was adjusted to 6.6 before use. Appropriate antibiotics 
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Fig. 5 Bioreactor production of MA using the P5.2:BC coculture 
system. a The coculture cell density, BC percentage and glycerol 
titer changes during the cultivation process. b The MA and pathway 
intermediate concentration changes during the cultivation process. 
Error bars represents SEM obtained from three independent bioreac-
tor runs
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(100 mg/L ampicillin, 50 mg/L kanamycin, and 34 mg/L 
chloramphenicol) were also added to the medium when 
needed. Except for the bioreactor experiments, the MA 
production was performed in 14 mL culture tubes.
For MA monoculture production, 2  mL glycerol 
medium was inoculated with 2 % (v/v) overnight E. coli 
P5g or P5s LB culture and cultivated under 37  °C with 
250 rpm shaking. Since the addition of IPTG at the time 
of inoculation resulted in poor cell growth, IPTG was 
supplemented to the culture 24  h after inoculation to 
induce the heterologous enzyme expression. MA produc-
tion was analyzed 72 h after induction.
For MA production using E. coli–E. coli cocultures, 
2  % (v/v) overnight LB cultures of the first strain (i.e. 
P5s or P5.2) and the second strain (i.e. BLS, BLH, BS or 
BC) were inoculated into 2 mL glycerol medium and the 
LB medium, respectively. After 24  h, the optical den-
sity (OD) at 600  nm of the two cultures was measured. 
The second strain was then harvested by centrifugation 
and appropriate amounts of the cell pellets were re-sus-
pended in the first strain culture to achieve the desired 
inoculation ratios. To be consistent with the single strain 
cultivation strategy, 0.1 mM IPTG was supplemented at 
the time of the second strain addition when E. coli BLS, 
BLH and BS (containing the inducible pathway and trans-
porter enzymes) were used. For P5s:BLH coculture, 5 ng/
mL tetracycline was also supplemented at the time of 
BLH addition to induce the expression of E. coli chaper-
ones groES/groEL carried by plasmid pG-KJE in BLH (the 
chaperone genes dnaK, dnaJ and grpE in pG-KJE were 
not induced for expression). The cocultures were then 
cultivated under 37 °C with 250 rpm shaking for another 
72 h.
For bioreactor cultivation, 14  mL overnight LB cul-
ture of E. coli P5.2 and appropriate amount (based on 
their cell densities) of overnight LB culture of E. coli BC 
were inoculated into 0.7  L glycerol medium to achieve 
1:1 inoculation ratio. The coculture cultivation was 
Table 3 The plasmids and E. coli strains utilized in this study
Plasmid Description Source
pET21c T7 promoter, AmpR Novagen
pET28a T7 promoter, KanR Novagen
pHACM-rpoA14 A gTME plasmid carrying a mutated alpha subunit of RNA polymerase for enhancing the shikimate pathway [30]
pAO pET21c carrying the catA and auxiliary ACIAD1443 genes from Acinetobacter calcoaceticus [20]
pAOM pACYCDuet-1 carrying the catA gene and ACIAD1443 genes [20]
pY pET28a carrying the aroY gene from Klebsiella pneumoniae [20]
pZ pET28a carrying the aroZ gene from Klebsiella pneumoniae [20]
pYZS pET28a carrying the aroY and aroZ genes from Klebsiella pneumonia and the E. coli shiA gene [20]
pYfsZ pET28a carrying the aroY and fused shiA-aroZ genes This study
pYpZ pY carrying aroZ that has a phage gIII leading sequence to localize AroZ enzyme into periplasm This study
pG-KJE A plasmid carrying E. coli chaperone dnaK-dnaJ-grpE and groES-groEL genes, CmR (only groES-groEL genes were induced  
for expression)
Clontech
pII A low copy number plasmid expressing weak green fluorecence protein, KanR [31]
pCS pACYCDuet-1 carrying the shiA gene that is under the control of a constitutive lacuv5 promoter [20]
pCS2 pCDFDuet-1 carrying the shiA gene that is under the control of a constitutive lacuv5 promoter [20]
pCYZAO pUC57(Kan) carrying the aroY, aroZ, catA and ACIAD1443 genes that are under the control of a constitutive Zymomonas 
mobilis pyruvate decarboxylase promoter
[20]
Strain Description Source
P5 E. coli K12 ΔpheA ΔtyrR lacZ::PLtetO-1-tyrA
fbraroGfbr tyrR::PLtetO-1-tyrA
fbraroGfbr hisH(L82R) ΔaroE ΔydiB [20]
P5g P5 harboring pHACM-rpoA14, pAO and pYZ [20]
P5s P5 harboring pHACM-rpoA14, pAO and pYZS [20]
P5fs P5 harboring pHACM-rpoA14, pAO and pYfsZ This study
P5pZ P5 harboring pHACM-rpoA14, pAO and pYpZ This study
P5cS P5 harboring pHACM-rpoA14, pCYZAO and pCS2 This study
P5.2 P5 harboring pII and pHACM-rpoA14 This study
BLS E. coli BL21(DE3) harboring pHACM-rpoA14, pAO and pYZS This study
BLH E. coli BL21(DE3) harboring pG-KJE, pAO and pYZS This study
BS E. coli BL21(DE3) harboring pYZS and pAOM This study
BC E. coli BL21(DE3) harboring pCYZAO and pCS This study
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performed in a 1.3-L BioFlo110 modular fermentor sys-
tem (New Brunswick Scientific) running at 1.5 L/min air 
flow rate, pH = 7.0 and 37 °C. The agitation rate was con-
trolled to maintain a constant DO of 12 %.
Assaying the cell‑to‑cell ratio in the coculture system
The ratio of the two constituent cell types in the E. coli–
E. coli coculture was determined using the method 
described before [20]. Specifically, 20 μL culture sample 
taken from the coculture system was first diluted around 
105 times using sterile water. 20 μL diluted culture was 
then spread onto a LB plate containing 40  mg/L X-gal 
(5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside) 
and 50  mg/L kanamycin. The plate was then incubated 
at 37 °C overnight. E. coli P5.2 with disrupted lacZ gene 
only formed white colonies on the X-gal plate, whereas 
the colonies of E. coli BC with intact chromosomal lacZ 
gene generated blue color on X-gal. The number of colo-
nies of each color were counted to determine the ratio of 
the two cell types in the coculture system.
Substrate and metabolite quantification
Glycerol concentration was monitored by HPLC analysis. 
Coculture samples were centrifuged at 12,000g for 2 min 
to collect cell-free broth, which was then filtered through 
0.2-μm-pore-size polytetrafluoroethylene membrane 
syringe filters (VWR International) before subjected to 
HPLC analysis. The HPLC system consisted of a Bio-rad 
HPX-87H column, a Waters 2695 separation module and 
a Waters 410 differential refractometer. Isocratic elu-
tion was conducted using 14 mM sulfuric acid as mobile 
phase at a flow rate of 0.7 mL/min.
The concentration of MA product and the pathway 
intermediates were determined by LC/MS/MS analysis. 
Cell-free broth was collected by 12,000g centrifugation 
for 5 min followed by filtration through 0.2-μm-pore-size 
polytetrafluoroethylene membrane syringe filters (VWR 
International). 10  μL 1  g/L p-coumaric acid internal 
standard was added into 1 mL of the filtered broth. 10 μL 
of the mixed solution was then injected into an Applied 
Biosystems API2000 LC/MS/MS running on a previously 
established method [20].
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